FDA Safety Database Analysis Identifies Delayed Postmarketing Events for Eculizumab in NMOSD - Bioengineer.org
FDA Safety Database Analysis Identifies Delayed Postmarketing Events for Eculizumab in NMOSD Bioengineer.org
Topics: Databases
Entities: Databases